Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Atopic dermatitis increases the risk of some autoimmune diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Allium hookeri extract may help promote hair growth and protect cells from damage.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Regenerative medicine is effective and safe for treating vitiligo.

Hydrangea serrata extract may promote hair growth and improve hair health.